Ridloff Elena

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ridloff Elena's trades of Kymera Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
204.03
Quantity 99,864
Value US$1,079,856
Transaction date
Proposed sale
Price
83.29
Quantity 4,600
Value US$383,134
Transaction date
Proposed sale
Price
79.48
Quantity 7,400
Value US$588,152
Transaction date
Proposed sale
Price
21.39
Quantity 34,500
Value US$737,955
Transaction date
Proposed sale
Price
48.60
Quantity 4,500
Value US$218,700
Transaction date
Proposed sale
Price
43.13
Quantity 12,000
Value US$517,560
Transaction date
Purchase
Price
19.00
Quantity 2,630 +inf%
Value US$49,970
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-11 2026-05-11
PlS Planned sale
1,809 +30.4%
372.91
US$3,081,524 		1,809 +30.4% 372.91 US$3,081,524
2026-05-11 2026-05-11
PrS Proposed sale
99,864
204.03
US$1,079,856 		99,864 204.03 US$1,079,856
2026-04-01 2026-04-01
PlS Planned sale
83,825 +39.9%
46.54
US$4,152,305 		83,825 +39.9% 46.54 US$4,152,305
2026-04-01 2026-04-01
PlS Planned sale
3,400 -73.9%
85.19
US$289,662 		3,400 -73.9% 85.19 US$289,662
2026-04-01 2026-04-01
PrS Proposed sale
4,600
83.29
US$383,134 		4,600 83.29 US$383,134
2026-04-01 2026-03-31
PlS Planned sale
7,400 -100.0%
85.37
US$631,739 		7,400 -100.0% 85.37 US$631,739
2026-03-31 2026-03-31
PrS Proposed sale
7,400
79.48
US$588,152 		7,400 79.48 US$588,152
2025-09-03 2025-09-02
PlS Planned sale
8,836 -18.7%
25.08
US$221,607 		8,836 -18.7% 25.08 US$221,607
2025-09-03 2025-08-29
PlS Planned sale
748 -1.6%
25.18
US$18,835 		748 -1.6% 25.18 US$18,835
2025-08-28 2025-08-28
PlS Planned sale
16,098 -25.1%
25.97
US$418,065 		16,098 -25.1% 25.97 US$418,065
2025-08-28 2025-08-27
PlS Planned sale
3,618 -5.3%
25.10
US$90,812 		3,618 -5.3% 25.10 US$90,812
2025-08-28 2025-08-26
PlS Planned sale
3,700 -5.2%
25.13
US$92,981 		3,700 -5.2% 25.13 US$92,981
2025-08-26 2025-08-26
PrS Proposed sale
33,000
24.06
US$793,980 		33,000 24.06 US$793,980
2025-08-21 2025-08-20
PlS Planned sale
17,500 -19.7%
22.69
US$397,075 		17,500 -19.7% 22.69 US$397,075
2025-08-20 2025-08-20
PrS Proposed sale
17,500
21.48
US$375,900 		17,500 21.48 US$375,900
2025-08-21 2025-08-19
PlS Planned sale
34,500 -27.9%
21.08
US$727,260 		34,500 -27.9% 21.08 US$727,260
2025-08-19 2025-08-19
PrS Proposed sale
34,500
21.39
US$737,955 		34,500 21.39 US$737,955
2025-06-11 2025-06-11
PrS Proposed sale
4,500
48.60
US$218,700 		4,500 48.60 US$218,700
2025-06-11 2025-06-11
PlS Planned sale
4,500 -100.0%
50.00
US$225,000 		4,500 -100.0% 50.00 US$225,000
2025-06-03 2025-06-03
PrS Proposed sale
12,000
43.13
US$517,560 		12,000 43.13 US$517,560
2025-06-03 2025-06-03
PlS Planned sale
4,800 -100.0%
47.00
US$225,600 		4,800 -100.0% 47.00 US$225,600
2025-06-03 2025-06-03
PlS Planned sale
7,200 -60.0%
45.50
US$327,600 		7,200 -60.0% 45.50 US$327,600
2021-02-08 2021-02-04
S Sale
2,051 -19.7%
50.61
US$103,801 		2,051 -19.7% 50.61 US$103,801
2021-01-08 2021-01-06
S Sale
1,016 -20.7%
53.34
US$54,193 		1,016 -20.7% 53.34 US$54,193
2020-10-16 2020-10-14
B Purchase
2,630 +inf%
19.00
US$49,970 		2,630 +inf% 19.00 US$49,970
2020-05-01 2020-04-30
S Sale
1,050 -32.4%
49.22
US$51,681 		1,050 -32.4% 49.22 US$51,681
2020-05-01 2020-04-29
PlS Planned sale
10,000 -100.0%
50.74
US$507,353 		10,000 -100.0% 50.74 US$507,353